Amplify Weight Loss Drug & Treatment ETF (THNR) Holdings $23.55 -0.37 (-1.55%) As of 06/13/2025 04:10 PM Eastern Add Compare Share Share Holdings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock Top 27 THNR HoldingsRankCompanyCurrent PriceWeightShares Held1NVONovo Nordisk A/S$79.90-1.4%13.78%5,6562LLYEli Lilly and Company$818.56+0.8%13.58%5363HIMSHims & Hers Health$55.33-3.2%6.47%3,5194Innovent Biologics, Inc.N/A6.39%23,0005Chugai Pharmaceutical Co., Ltd.N/A5.72%3,1006TEVATeva Pharmaceutical Industries$17.00-4.0%5.34%8,6947WSTWest Pharmaceutical Services$221.77-1.4%4.72%6408AZNAstraZeneca$74.42-0.8%4.66%1,8749Roche Holding AGN/A4.62%41810PFEPfizer$24.51-1.3%4.60%5,592 Get the Latest News and Ratings for THNR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Amplify Weight Loss Drug & Treatment ETF and its competitors with MarketBeat's FREE daily newsletter. 11AMGNAmgen$295.22-0.7%4.55%45812MRKMerck & Co., Inc.$81.68-0.2%4.05%1,51213TMOThermo Fisher Scientific$402.12-3.2%4.04%28514Mitsubishi Chemical Group CorporationN/A3.67%19,70015Zealand Pharma A/SN/A2.32%96016GPCRStructure Therapeutics$21.68-2.4%1.94%2,46617Gerresheimer AGN/A1.68%66618VKTXViking Therapeutics$26.08-8.7%1.62%1,64219Bachem Holding AGN/A1.32%61120Ypsomed Holding AGN/A1.16%7021The United Laboratories International Holdings LimitedN/A1.12%18,00022Hanmi Pharm. Co., Ltd.N/A0.73%9423Gubra A/SN/A0.66%31924Short-Term Investment Trust - Invesco Government & Agency PortfolioN/A0.55%15,80825DEPOSITS WITH BROKER FOR SHORT POSITIONSN/A0.25%69,048,49726ALTAltimmune$6.92-3.2%0.23%1,14727OPKOPKO Health$1.33-0.7%0.22%4,649 Geographic ExposureUnited States140.7%Cayman Islands8.9%Japan8.6%Switzerland5.7%Denmark2.3%Germany1.2%Korea, Republic of0.7%Currency ExposureUSD170.4%HKD8.9%JPY8.6%CHF7.0%DKK3.2%EUR1.2%KRW0.7%Sector ExposureHealth Care163.8%Materials4.7%Consumer Discretionary0.5%Industry ExposureBiotechnology128.1%Health Care Equipment & Supplies18.0%Health Care Providers & Services13.0%Chemicals4.7%Pharmaceuticals3.5%Life Sciences Tools & Services1.2%Diversified Consumer Services0.5%SubIndustry ExposureBiotechnology128.1%Health Care Services13.0%Health Care Supplies10.4%Life Sciences Tools & Services8.8%Pharmaceuticals4.0%Diversified Chemicals3.4%Commodity Chemicals1.3%Coupon Exposure4-60.6%Maturity Exposure5-100.6% Related Companies and Tools Related Companies Grayscale Bitcoin Adopters ETF Holdings iShares Health Innovation Active ETF Holdings iShares Virtual Work and Life Multisector ETF Holdings ProShares S&P Global Core Battery Metals ETF Holdings KraneShares 100% KWEB Defined Outcome Through January 2026 ETF Holdings Blue Horizon BNE ETF Holdings ProShares Decline of the Retail Store ETF Holdings ProShares Ultra Nasdaq Cloud Computing ETF Holdings iShares Breakthrough Environmental Solutions ETF Holdings Tema Luxury ETF Holdings This page (NYSEARCA:THNR) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amplify Weight Loss Drug & Treatment ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Amplify Weight Loss Drug & Treatment ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy THNR Stock Free THNR Stock Alerts